Anti-ADAM12 antibodies for the treatment of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160208016A1
SERIAL NO

14915182

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure concerns monoclonal antibodies directed to the pro-domain of ADAM 12 and their use in the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF COPENHAGENNØRREGADE 10 COPENHAGEN K 1165

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Albrechtsen, Reidar Klampenborg, DK 1 0
Fröhlich, Camilla Copenhagen Ø, DK 12 10
Wewer, Ulla Klampenborg, DK 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation